KBAL LTD

Active Bolton

Manufacture of pharmaceutical preparations

0 employees website.com
Manufacture of pharmaceutical preparations
K

KBAL LTD

Manufacture of pharmaceutical preparations

Founded 22 Apr 2024 Active Bolton, England 0 employees website.com
Manufacture of pharmaceutical preparations
Accounts Due 31 Jan 2027 9 months remaining
Confirmation Submitted 26 Feb 2026 Next due 12 Mar 2027 10 months remaining
Net assets £60
Total assets £60
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

80 St. Georges Road Bolton BL1 2DD England

Full company profile for KBAL LTD (15666596), an active company based in Bolton, England. Incorporated 22 Apr 2024. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2025–2025)

Cash in Bank

£60.00

Net Assets

£60.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Morgan, LewisDirectorBritishUnited Kingdom4922 Apr 2024Active

Shareholders

Shareholders (4)

Refine Group Holdings Limited
33.3%
20
Refine Pharma Ltd
33.3%
20

Persons with Significant Control

Persons with Significant Control (4)

4 Active 1 Ceased
Notified 26 Feb 2026
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Mr Bradley Steven Tyson

British

Active
Notified 17 Oct 2025
Residence England
DOB October 1995
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Bj Pharma (uk) Ltd

United Kingdom

Active
Notified 22 Apr 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Lewis Morgan

British

Active
Notified 22 Apr 2024
Residence United Kingdom
DOB August 1976
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Adam Mason

Ceased 30 Jul 2025

Ceased

Group Structure

Group Structure

REFINE PHARMA LTD united kingdom
KBAL LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Unit 6 Building B, Chesterwell Plaza, Leda Way, Colchester (CO4 6EE) COLCHESTER
Leasehold-12 Sept 2024
Unit 6 Building B, Chesterwell Plaza, Leda Way, Colchester (CO4 6EE)
Leasehold
Added 12 Sept 2024
District COLCHESTER

Documents

Company Filings

DateCategoryDescriptionDocument
26 Feb 2026Persons With Significant ControlRefine Group Holdings Limited notified as a person with significant control
26 Feb 2026Persons With Significant ControlCessation of Bradley Steven Tyson as a person with significant control on 26 Feb 2026
26 Feb 2026Confirmation StatementConfirmation statement made on 26 Feb 2026 with updates
17 Oct 2025Persons With Significant ControlBradley Steven Tyson notified as a person with significant control
17 Oct 2025Persons With Significant ControlChange to Bj Pharma (Uk) Ltd as a person with significant control on 17 Oct 2025
26 Feb 2026 Persons With Significant Control

Refine Group Holdings Limited notified as a person with significant control

26 Feb 2026 Persons With Significant Control

Cessation of Bradley Steven Tyson as a person with significant control on 26 Feb 2026

26 Feb 2026 Confirmation Statement

Confirmation statement made on 26 Feb 2026 with updates

17 Oct 2025 Persons With Significant Control

Bradley Steven Tyson notified as a person with significant control

17 Oct 2025 Persons With Significant Control

Change to Bj Pharma (Uk) Ltd as a person with significant control on 17 Oct 2025

Recent Activity

Latest Activity

Refine Group Holdings Limited notified as a person with significant control

2 months ago on 26 Feb 2026

Cessation of Bradley Steven Tyson as a person with significant control on 26 Feb 2026

2 months ago on 26 Feb 2026

Confirmation statement made on 26 Feb 2026 with updates

2 months ago on 26 Feb 2026

Bradley Steven Tyson notified as a person with significant control

6 months ago on 17 Oct 2025

Change to Bj Pharma (Uk) Ltd as a person with significant control on 17 Oct 2025

6 months ago on 17 Oct 2025